Publications by authors named "Monica Garzon"

Claim this Profile
M
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Ana Giménez-Capitán, Jillian Bracht, Juan José García, Núria Jordana-Ariza, Beatriz García

Clin Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
Maria Gonzalez-Cao, Teresa Morán, Judith Dalmau, Javier Garcia-Corbacho, Jillian W P Bracht, Monica Garzon

JAMA Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report.
Roxana Reyes, Clara Mayo-de-Las-Casas, Cristina Teixidó, Carlos Cabrera, Elba Marín

Clin Lung Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
Kirstine Jacobsen, Jordi Bertran-Alamillo, Miguel Angel Molina, Cristina Teixidó, Niki Karachaliou

Nat Commun· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Umberto Malapelle, Clara Mayo de-Las-Casas, Danilo Rocco, Monica Garzon, Pasquale Pisapia

Br J Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy in Non-Small Cell Lung Cancer.
Miguel A Molina-Vila, Clara Mayo-de-Las-Casas, Ana Giménez-Capitán, Núria Jordana-Ariza, Mónica Garzón

Front Med (Lausanne)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.
Mónica Garzón, Sergi Villatoro, Cristina Teixidó, Clara Mayo, Alejandro Martínez

Transl Lung Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of circulating free DNA for monitoring epidermal growth factor receptor mutations in advanced non-small cell lung cancer patients: a case report.
Clara Mayo de Las Casas, Maria Gonzalez-Cao, Santiago Viteri Ramirez, Nuria Jordana Ariza, Ariadna Balada

Transl Lung Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis